125 related articles for article (PubMed ID: 30216892)
1. Generation of induced pluripotent stem cell line(ZZUi006-A)from a patient with myotonic dystrophy type 1.
Wang Y; Wang Z; Sun H; Shi C; Yang J; Liu Y; Liu H; Zhang S; Zhang L; Xu Y; Zhang J
Stem Cell Res; 2018 Oct; 32():61-64. PubMed ID: 30216892
[TBL] [Abstract][Full Text] [Related]
2. Lymphoblastoids cell lines - Derived iPSC line from a 26-year-old myotonic dystrophy type 1 patient carrying (CTG)
Martineau L; Racine V; Benichou SA; Puymirat J
Stem Cell Res; 2018 Jan; 26():103-106. PubMed ID: 29274549
[TBL] [Abstract][Full Text] [Related]
3. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
[TBL] [Abstract][Full Text] [Related]
4. Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability.
Ueki J; Nakamori M; Nakamura M; Nishikawa M; Yoshida Y; Tanaka A; Morizane A; Kamon M; Araki T; Takahashi MP; Watanabe A; Inagaki N; Sakurai H
Sci Rep; 2017 Feb; 7():42522. PubMed ID: 28211918
[TBL] [Abstract][Full Text] [Related]
5. Generation of induced pluripotent stem cell line (ZZUi015-A) from a DM1 patient with cataract.
Li T; Sun H; Wang Z; Zhang Q; Chen N; Zhang K; Wang Y; Xu Y
Stem Cell Res; 2022 Jan; 58():102623. PubMed ID: 34915310
[TBL] [Abstract][Full Text] [Related]
6. Genome modification leads to phenotype reversal in human myotonic dystrophy type 1 induced pluripotent stem cell-derived neural stem cells.
Xia G; Gao Y; Jin S; Subramony SH; Terada N; Ranum LP; Swanson MS; Ashizawa T
Stem Cells; 2015 Jun; 33(6):1829-38. PubMed ID: 25702800
[TBL] [Abstract][Full Text] [Related]
7. Lymphoblastoid cell lines derived from iPSCs of a myotonic dystrophy type 1 patient carrying 700 CTG repeats (CBRCULi007-A) and a control (CBRCULi006-A).
Chahine M; Jauvin D; Pierre M; Puymirat J; Boutjdir M
Stem Cell Res; 2023 Sep; 71():103148. PubMed ID: 37352653
[TBL] [Abstract][Full Text] [Related]
8. Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy.
Gao Y; Guo X; Santostefano K; Wang Y; Reid T; Zeng D; Terada N; Ashizawa T; Xia G
Mol Ther; 2016 Aug; 24(8):1378-87. PubMed ID: 27203440
[TBL] [Abstract][Full Text] [Related]
9. Generation of two induced pluripotent stem cells lines from Mucopolysaccharydosis IIIA patient: IMEDEAi004-A and IMEDEAi004-B.
Vallejo S; Fleischer A; Martín JM; Sánchez A; Palomino E; Bachiller D
Stem Cell Res; 2018 Oct; 32():110-114. PubMed ID: 30269021
[TBL] [Abstract][Full Text] [Related]
10. Generation of induced pluripotent stem cell line (ZZUi0016-A) from dermal fibroblasts of a normal human.
Gao Y; Wang Y; Wang Z; Sun H; Zhang R; Yang J; Liu Y; Liu H; Zhang Q; Zhang S; Shi C; Xu Y; Song B
Stem Cell Res; 2020 Mar; 43():101717. PubMed ID: 32007761
[TBL] [Abstract][Full Text] [Related]
11. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.B11.
Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
Stem Cell Res; 2016 May; 16(3):589-92. PubMed ID: 27346191
[TBL] [Abstract][Full Text] [Related]
12. Derivation of DM1 affected human embryonic stem cell line Genea067.
Dumevska B; Main H; McKernan R; Goel D; Schmidt U
Stem Cell Res; 2016 Mar; 16(2):437-9. PubMed ID: 27346009
[TBL] [Abstract][Full Text] [Related]
13. Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery.
Mondragon-Gonzalez R; Perlingeiro RCR
Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29898953
[TBL] [Abstract][Full Text] [Related]
14. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11.
Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
Stem Cell Res; 2016 May; 16(3):553-6. PubMed ID: 27346190
[TBL] [Abstract][Full Text] [Related]
15. Generation of three myotonic dystrophy type 1 patient iPSC lines (CBRCULi018-A, CBRCULi019-A, CBRCULi020-A) derived from lymphoblastoid cell lines for disease modelling and therapeutic research.
Pierre M; Jauvin D; Puymirat J; Boutjdir M; Chahine M
Stem Cell Res; 2024 Apr; 76():103375. PubMed ID: 38490135
[TBL] [Abstract][Full Text] [Related]
16. Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease.
Savchenko E; Marote A; Russ K; Collin A; Goldwurm S; Roybon L; Pomeshchik Y
Stem Cell Res; 2018 Mar; 27():78-81. PubMed ID: 29334629
[TBL] [Abstract][Full Text] [Related]
17. Generation of induced pluripotent stem cell line (ZZUi004-A) from urine sample of a patient with spinocerebellar ataxia type 3.
Wang Y; Shi C; Wang Z; Sun H; Yang Z; Zhang F; Liu Y; Liu H; Jiang C; Zhang S; Xu Y; Wen X
Stem Cell Res; 2018 Apr; 28():71-74. PubMed ID: 29444500
[TBL] [Abstract][Full Text] [Related]
18. Generation of induced pluripotent stem cell lines from pediatric patients with congenital myotonic dystrophy (CBRCULi012-A and CBRCULi013-A) and age-matched controls (CBRCULi010-A and CBRCULi011-A).
De Serres-Bérard T; Jauvin D; Puymirat J; Chahine M
Stem Cell Res; 2023 Oct; 72():103234. PubMed ID: 37871474
[TBL] [Abstract][Full Text] [Related]
19. Generation of neural cells from DM1 induced pluripotent stem cells as cellular model for the study of central nervous system neuropathogenesis.
Xia G; Santostefano KE; Goodwin M; Liu J; Subramony SH; Swanson MS; Terada N; Ashizawa T
Cell Reprogram; 2013 Apr; 15(2):166-77. PubMed ID: 23550732
[TBL] [Abstract][Full Text] [Related]
20. Generation of four myotonic dystrophy type 1 patient iPSC lines (CBRCULi002-A, CBRCULi003-A, CBRCULi004-A, CBRCULi005-A) and a control (CBRCULi001-A) derived from lymphoblastoids cell lines.
Jauvin D; Pierre M; Boutjdir M; Puymirat J; Chahine M
Stem Cell Res; 2023 Mar; 67():103037. PubMed ID: 36739767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
